These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
776 related articles for article (PubMed ID: 27590706)
1. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort. Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706 [TBL] [Abstract][Full Text] [Related]
2. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment. Fernández-Blázquez MA; Ávila-Villanueva M; Maestú F; Medina M J Alzheimers Dis; 2016 Mar; 52(1):271-81. PubMed ID: 27060949 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment. Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799 [TBL] [Abstract][Full Text] [Related]
4. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype. Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351 [TBL] [Abstract][Full Text] [Related]
5. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Farias ST; Mungas D; Reed BR; Harvey D; DeCarli C Arch Neurol; 2009 Sep; 66(9):1151-7. PubMed ID: 19752306 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145 [TBL] [Abstract][Full Text] [Related]
7. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set. Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489 [TBL] [Abstract][Full Text] [Related]
8. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial. Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479 [TBL] [Abstract][Full Text] [Related]
9. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years. Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165 [TBL] [Abstract][Full Text] [Related]
10. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Amieva H; Letenneur L; Dartigues JF; Rouch-Leroyer I; Sourgen C; D'Alchée-Birée F; Dib M; Barberger-Gateau P; Orgogozo JM; Fabrigoule C Dement Geriatr Cogn Disord; 2004; 18(1):87-93. PubMed ID: 15087583 [TBL] [Abstract][Full Text] [Related]
11. Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment. Kang M; Li C; Mahajan A; Spat-Lemus J; Durape S; Chen J; Gurnani AS; Devine S; Auerbach SH; Ang TFA; Sherva R; Qiu WQ; Lunetta KL; Au R; Farrer LA; Mez J JAMA Psychiatry; 2024 Oct; 81(10):993-1002. PubMed ID: 38959008 [TBL] [Abstract][Full Text] [Related]
12. Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort. Dufouil C; Dubois B; Vellas B; Pasquier F; Blanc F; Hugon J; Hanon O; Dartigues JF; Harston S; Gabelle A; Ceccaldi M; Beauchet O; Krolak-Salmon P; David R; Rouaud O; Godefroy O; Belin C; Rouch I; Auguste N; Wallon D; Benetos A; Pariente J; Paccalin M; Moreaud O; Hommet C; Sellal F; Boutoleau-Bretonniére C; Jalenques I; Gentric A; Vandel P; Azouani C; Fillon L; Fischer C; Savarieau H; Operto G; Bertin H; Chupin M; Bouteloup V; Habert MO; Mangin JF; Chêne G; Alzheimers Res Ther; 2017 Aug; 9(1):67. PubMed ID: 28851447 [TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study. Udeh-Momoh C; Price G; Ropacki MT; Ketter N; Andrews T; Arrighi HM; Brashear HR; Robb C; Bassil DT; Cohn M; Curry LK; Su B; Perera D; Giannakopoulou P; Car J; Ward HA; Perneczky R; Novak G; Middleton L J Prev Alzheimers Dis; 2019; 6(4):256-266. PubMed ID: 31686098 [TBL] [Abstract][Full Text] [Related]
14. Early Functional Limitations in Cognitively Normal Older Adults Predict Diagnostic Conversion to Mild Cognitive Impairment. Farias ST; Lau K; Harvey D; Denny KG; Barba C; Mefford AN J Am Geriatr Soc; 2017 Jun; 65(6):1152-1158. PubMed ID: 28306147 [TBL] [Abstract][Full Text] [Related]
15. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease. Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836 [TBL] [Abstract][Full Text] [Related]
16. Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea). Roh HW; Hong CH; Lee Y; Lee KS; Chang KJ; Kang DR; Lee JD; Choi SH; Kim SY; Na DL; Seo SW; Kim DK; Back JH; Chung YK; Lim KY; Noh JS; Son SJ J Alzheimers Dis; 2016 May; 53(2):463-73. PubMed ID: 27163831 [TBL] [Abstract][Full Text] [Related]
17. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia. Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387 [TBL] [Abstract][Full Text] [Related]
18. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
19. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment. Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810 [TBL] [Abstract][Full Text] [Related]
20. Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers. Xu WL; Caracciolo B; Wang HX; Santoni G; Winblad B; Fratiglioni L J Alzheimers Dis; 2013; 33(2):507-15. PubMed ID: 23247007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]